ReviewMolecular medicine reports2026
Mechanism and therapeutic prospects of adipose tissue B lymphocytes in obesity and obesity‑associated metabolic diseases (Review).
Review in Molecular medicine reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Obesity has become a global epidemic and a notable trigger for numerous chronic diseases, including insulin resistance, type II diabetes, cardiovascular disease, non‑alcoholic fatty liver disease and cancer, which is characterized by chronic low‑grade inflammation in the adipose tissue. Traditionally, adipose tissue macrophages were considered the central drivers of obesity‑associated inflammation; however, studies have revealed that B cells play a notable role in adipose tissue inflammation and metabolic homeostasis. The present review systematically elaborates on the distribution and functions of B cells within adipose tissue, with a focus on the dynamic changes in B cell subsets during the progression of obesity, the mechanisms in promoting metabolic diseases, and the potential applications and challenges of targeting B cells for the treatment of obesity‑related metabolic disorders, in order to provide new insights into the mechanistic understanding and therapy of obesity and its associated metabolic diseases.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.